Investor Relations
The convergence moment
is now.
PonieTech Industries is seeking seed investment to advance Project Juvet the world's first quantum-photonic human-robot interface through Phase 1 and Phase 2 development. The right investors are having this conversation with us now.
The Opportunity at a Glance
Market Opportunity
Four segments.
One unsolved problem.
Every domain that uses teleoperated robotics shares the same fundamental deficit the operator cannot feel what the robot touches. This is the embodiment gap. PonieTech is the first company building a biological solution to a problem that mechanical approaches have failed to solve for eighty years.
The $70B total addressable market represents four distinct segments each with documented, economically significant unmet need. The serviceable addressable market in the initial commercial phase is surgical robotics the earliest regulatory pathway and the most clearly defined reimbursement infrastructure.
Funding Structure
Two rounds.
Fully mapped to milestones.
Seed Round
Now Open- Phase 1 Bioprinting foundation & construct fabrication
- Phase 2 Micro-ILED integration & ChR2 transduction
- Personnel founding team through Year 2
- Lab infrastructure & CRO partnerships
- Provisional patent applications 5 priority families
- Regulatory strategy development pre-IND planning
Series A
Month 18 Target- Phase 3 Entanglement layer & QKD integration
- Phase 4 Full system integration & first prototype
- FDA pre-submission meeting & regulatory development
- Non-provisional patent prosecution 5 families
- Team expansion R&D, regulatory, commercial leads
- First pilot deployment & clinical evidence generation
The Technology
Four layers.
One biological construct.
Entangled Ca²⁺ ion-pair mesh reads neural pre-motor signals at sensitivity beyond the classical noise floor.
1.4× beyond classical limit Stanford 2024Quantum key distribution physically impossible to intercept or jam. Security is a property of physics, not software.
92% fidelity University of Innsbruck 2024Sub-milliwatt photonic inference chip powered by body heat. No cloud. No battery. No delay.
<1mW · <5ms latencyChR2-expressing cells deliver biological haptic sensation. The operator does not feel a simulation of touch. The operator feels.
>90% cell viability day 7 MIT Raman Lab 2024Intellectual Property
Five patent families.
Five competitive moats.
Looking Glass Robotics has identified five priority patent families covering the core novel contributions of the Project Juvet architecture. Provisional applications are being filed before any external partner disclosures. Non-provisional prosecution begins following Phase 1 validation.
The IP strategy also encompasses Madrid Protocol international filing in EU, Japan, South Korea, China, and Israel concurrent with US non-provisional filing, and trademark registration for PonieTech Industries, Looking Glass Robotics, and Project Juvet.
- Critical File First Optogenetic Haptic Feedback System (Class 607, 600)
- Critical Quantum Dot Bioink Formulation (Class 424, 977)
- Critical Micro-ILED Array in Bioprinted Tissue (Class 438, 607)
- High Priority QKD Pairing Protocol for Tissue Interfaces (Class 380, 398)
- High Priority Entangled Ion-Pair Biometric Sensor (Class 600, 977)
Request the Investor Package
The right conversation
starts here.
Request the full investor deck, operating budget model, technical research paper, and bill of materials. All materials provided under NDA to qualified investors.
All investor materials provided under NDA. We respond to every serious inquiry within 24 hours.